Skip to Main Content

Paper Details

Angiopoietin-Like4 Is a Novel Marker of COVID-19 Severity.
Crit Care Explor
4
2022
ANGPTL4, Angiopoietin-Like4, Angiopoietin-like 4, COVID-19, Vascular dysfunction, acute respiratory distress syndrome, capillary leak, fibroblasts, lung single nucleus RNA, patients, pulmonary alveolar, pulmonary epithelial cells, single, single-nuclear RNA gene, snRNA, type 2 epithelial cells, vascular injury, venous thromboembolism
Author NameAffiliation
Pavan K BhatrajuUniversity of Washington Medical Center
Pavan K BhatrajuUniversity of Washington, Sepsis Center of Research Excellence-University of Washington (SCORE-UW)
Pavan K BhatrajuKidney Research Institute, University of Washington Medical Center
Ian B StanawayKidney Research Institute, University of Washington Medical Center
Richard GreenUniversity of Washington Medical Center
Vishakha K Kumar
Michael GaleUniversity of Washington
George L AnesiPerelman School of Medicine, University of Pennsylvania
David M Brett-MajorGlobal Center for Health Security, University of Nebraska Medical Center
Jonathan E SevranskyEmory University
Jonathan E Sevransky
Sina A GharibUniversity of Washington Medical Center
Timothy M UyekiCenters for Disease Control and Prevention
David R CrosslinTulane University
David R CrosslinTulane University
Gail P JarvikUniversity of Washington Medical Center
Gail P JarvikUniversity of Washington Medical Center
Carmen MikacenicBenaroya Research Institute
  • 1 - 18

Datasets

Release 1.2